Cispharma Inc is categorized under Wholesale Pharmaceutical Products in Cranbury, NJ .
Cispharma Inc was established in 0, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Hasmukh Patel, Partner at the company’s single location by writing to 1212 Cranbury South River Road, Cranbury, New Jersey NJ 08512 or by phoning (609) 235-9807. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cispharma Inc |
| Contact Person: | Hasmukh Patel, Partner |
| Address: | 1212 Cranbury South River Road, Cranbury, New Jersey 08512 |
| Phone Number: | (609) 235-9807 |
| Website Address: | cispharmausa.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Cispharma Inc was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Hasmukh Patel, Partner for inquiries that concern Cispharma Inc by calling the company number (609) 235-9807, as your correspondence is most welcome. Additionally, the physical location of the single location of Cispharma Inc can be found at the coordinates 40.31238,-74.52621 as well as the street address 1212 Cranbury South River Road in Cranbury, New Jersey 08512.
For its online presence, you may visit Cispharma Inc’s website at cispharmausa.com and engage with its social media outlets through on Twitter and on Facebook.